LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928,594 | -43.1% | 851,921 | +19.6% | 0.00% | – |
| Q2 2023 | $1,631,339 | -2.5% | 712,375 | +3.5% | 0.00% | -100.0% |
| Q1 2023 | $1,673,325 | +25.9% | 688,611 | -1.1% | 0.00% | – |
| Q4 2022 | $1,329,245 | -16.4% | 695,940 | +5.1% | 0.00% | -100.0% |
| Q3 2022 | $1,590,000 | +96.5% | 662,478 | +52.4% | 0.00% | – |
| Q2 2022 | $809,000 | -22.8% | 434,564 | -13.3% | 0.00% | – |
| Q1 2022 | $1,048,000 | -45.6% | 501,128 | +2.6% | 0.00% | -100.0% |
| Q4 2021 | $1,925,000 | -15.9% | 488,418 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $2,289,000 | +6.2% | 475,794 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $2,156,000 | -13.2% | 469,704 | +11.0% | 0.00% | 0.0% |
| Q1 2021 | $2,485,000 | +117.6% | 423,226 | +26.8% | 0.00% | – |
| Q4 2020 | $1,142,000 | +168.7% | 333,786 | +13.1% | 0.00% | – |
| Q3 2020 | $425,000 | -25.0% | 295,129 | +4.0% | 0.00% | – |
| Q2 2020 | $567,000 | +8.8% | 283,894 | +6.4% | 0.00% | – |
| Q1 2020 | $521,000 | -52.2% | 266,693 | +1.5% | 0.00% | -100.0% |
| Q4 2019 | $1,091,000 | +56.5% | 262,850 | +13.6% | 0.00% | – |
| Q3 2019 | $697,000 | -58.8% | 231,411 | -13.9% | 0.00% | -100.0% |
| Q2 2019 | $1,692,000 | +14.7% | 268,914 | +1.4% | 0.00% | 0.0% |
| Q1 2019 | $1,475,000 | -14.4% | 265,230 | +2.2% | 0.00% | 0.0% |
| Q4 2018 | $1,724,000 | -39.3% | 259,501 | -2.5% | 0.00% | -50.0% |
| Q3 2018 | $2,841,000 | -1.8% | 266,245 | +10.4% | 0.00% | 0.0% |
| Q2 2018 | $2,893,000 | +48.9% | 241,061 | +6.4% | 0.00% | 0.0% |
| Q1 2018 | $1,943,000 | -10.5% | 226,635 | +3.2% | 0.00% | 0.0% |
| Q4 2017 | $2,170,000 | -13.5% | 219,557 | +7.6% | 0.00% | 0.0% |
| Q3 2017 | $2,509,000 | -21.1% | 204,129 | +5.6% | 0.00% | -33.3% |
| Q2 2017 | $3,181,000 | +15.7% | 193,318 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $2,749,000 | -36.7% | 191,685 | -38.9% | 0.00% | -40.0% |
| Q4 2016 | $4,342,000 | -23.8% | 313,911 | -0.4% | 0.01% | -28.6% |
| Q3 2016 | $5,695,000 | +30.0% | 315,145 | +3.3% | 0.01% | +40.0% |
| Q2 2016 | $4,380,000 | +140.4% | 305,203 | +100.2% | 0.01% | +150.0% |
| Q1 2016 | $1,822,000 | -8.2% | 152,468 | +2.3% | 0.00% | -33.3% |
| Q4 2015 | $1,985,000 | +27.7% | 149,093 | +3.0% | 0.00% | +50.0% |
| Q3 2015 | $1,555,000 | +46.8% | 144,755 | +10.1% | 0.00% | +100.0% |
| Q2 2015 | $1,059,000 | – | 131,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |